Hans Rogl

Hans Rogl has extensive work experience in the pharmaceutical industry. Hans is currently working as the Head of Manufacturing Science & Technology at ITM Isotope Technologies Munich SE since 2023. Prior to this, they held various roles at MorphoSys, including Head of Biologics Development & Analytics, Director/ Head of MSAT (Technical Development), and Director/ Deputy Head of Production from 2019 to 2023. Before joining MorphoSys, they worked at Roche as the Manager of Pharma Technical Regulatory Affairs CMC-RA from 2014 to 2019. Hans also has experience at Boehringer Ingelheim as the Associate Director of Protein Science, Formulation & Purification Development from 2012 to 2014, and at Roche as the Manager of Development Downstream Processing, Pharma Biotech Penzberg and GMP Production Line Manager Pharma Biotech from 2003 to 2011. Hans began their career as a Postdoc at the Centre d'Immunologie de Marseille Luminy in 2001.

Hans Rogl obtained their Ph.D. in Dr. phil. nat. from the Max-Planck-Institut für Biophysik, Frankfurt am Main, from 1996 to 2000.